Showing results (261-270 of 488) with videos related to
Sort By:
Pageof 49
ERJ Open Research|December 9, 2021
Granulomatous-lymphocytic interstitial lung disease: an international research prioritisationJohn R Hurst, S Hamza Abbas, Heba M Bintalib, et al.Journal of Clinical Immunology|April 21, 2015
Enteroviral Infection in a Patient with BLNK Adaptor Protein DeficiencyAdeeb NaserEddin, Oded Shamriz, Baerbel Keller, et al.BMJ Open|July 2, 2020
Relationship of CT densitometry to lung physiological parameters and health status in alpha-1 antitrypsin deficiency: initial report of a centralised database of the NIHR rare diseases translational research collaborativeDiana Crossley, James Stockley, Charlotte E Bolton, et al.JMIR Mhealth and Uhealth|November 13, 2020
Once Daily Versus Overnight and Symptom Versus Physiological Monitoring to Detect Exacerbations of Chronic Obstructive Pulmonary Disease: Pilot Randomized Controlled TrialAhmed M Al Rajeh, Yousef Saad Aldabayan, Abdulelah Aldhahir, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 19, 2019
Urban-Rural Disparities in Chronic Obstructive Pulmonary Disease Management and Access in UgandaNicole M Robertson, Emily M Nagourney, Suzanne L Pollard, et al.Scientific Reports|June 20, 2023
Delineating COVID-19 subgroups using routine clinical data identifies distinct in-hospital outcomesBojidar Rangelov, Alexandra Young, Watjana Lilaonitkul, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 30, 2011
Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptorsMatthias Kreuzaler, Melanie Rauch, Ulrich Salzer, et al.Nature Communications|December 19, 2025
Recombination junctions from antibody isotype switching classify immune and DNA repair dysfunctionClara Vázquez García, Benedikt Obermayer, Baerbel Keller, et al.HIV/AIDS (Auckland, N.Z.)|June 18, 2025
Chronic Obstructive Pulmonary Disease in People with HIV: an Evidence-Based ReviewAndrew T Read, Jane Akodu, Tristan J Barber, et al.Journal of the American Society of Nephrology : JASN|January 23, 2003
15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacyRainer Birck, Klaus Warnatz, Hanns M Lorenz, et al.Pageof 49